Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIDE: Gefitinib + Paclitaxel/Carboplatin in NSCLC
NCT01196234Phase 2Completed
- Sponsor
- Asan Medical Center
- Start
- Dec 2009
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by Asan Medical Center. Started Dec 2009; status: completed.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01196234.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01196234.